Rhumbline Advisers Orasure Technologies Inc Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Orasure Technologies Inc stock. As of the latest transaction made, Rhumbline Advisers holds 113,970 shares of OSUR stock, worth $434,225. This represents 0.0% of its overall portfolio holdings.

Number of Shares
113,970
Previous 118,332 3.69%
Holding current value
$434,225
Previous $504,000 3.57%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$3.93 - $4.59 $17,142 - $20,021
-4,362 Reduced 3.69%
113,970 $486,000
Q2 2024

Aug 01, 2024
SELL
$4.2 - $6.18 $466,859 - $686,950
-111,157 Reduced 48.44%
118,332 $504,000
Q1 2024

May 09, 2024
BUY
$6.08 - $8.28 $21,304 - $29,013
3,504 Added 1.55%
229,489 $1.41 Million
Q4 2023

Feb 08, 2024
SELL
$5.13 - $8.35 $68,429 - $111,380
-13,339 Reduced 5.57%
225,985 $1.85 Million
Q3 2023

Nov 09, 2023
SELL
$4.4 - $6.91 $12,170 - $19,113
-2,766 Reduced 1.14%
239,324 $1.42 Million
Q2 2023

Aug 08, 2023
BUY
$4.88 - $7.39 $10,291 - $15,585
2,109 Added 0.88%
242,090 $1.21 Million
Q1 2023

May 11, 2023
BUY
$4.66 - $6.52 $46,152 - $64,574
9,904 Added 4.3%
239,981 $1.45 Million
Q4 2022

Feb 14, 2023
BUY
$3.7 - $5.29 $15,443 - $22,080
4,174 Added 1.85%
230,077 $1.11 Million
Q3 2022

Nov 10, 2022
BUY
$2.72 - $4.61 $24,458 - $41,453
8,992 Added 4.15%
225,903 $856,000
Q2 2022

Aug 11, 2022
BUY
$2.71 - $7.12 $20,633 - $54,211
7,614 Added 3.64%
216,911 $588,000
Q1 2022

May 12, 2022
BUY
$6.62 - $9.33 $1,588 - $2,239
240 Added 0.11%
209,297 $1.42 Million
Q4 2021

Feb 10, 2022
BUY
$8.3 - $11.29 $60,780 - $82,676
7,323 Added 3.63%
209,057 $1.82 Million
Q3 2021

Nov 12, 2021
SELL
$9.73 - $13.38 $265,512 - $365,113
-27,288 Reduced 11.92%
201,734 $2.28 Million
Q2 2021

Aug 05, 2021
BUY
$9.02 - $11.68 $79,727 - $103,239
8,839 Added 4.01%
229,022 $2.32 Million
Q1 2021

May 06, 2021
BUY
$9.53 - $15.42 $26,703 - $43,206
2,802 Added 1.29%
220,183 $2.57 Million
Q4 2020

Feb 10, 2021
BUY
$10.35 - $15.94 $154,711 - $238,271
14,948 Added 7.38%
217,381 $2.3 Million
Q3 2020

Nov 12, 2020
SELL
$10.24 - $19.58 $145,766 - $278,721
-14,235 Reduced 6.57%
202,433 $2.46 Million
Q2 2020

Aug 13, 2020
SELL
$9.71 - $17.87 $39,811 - $73,267
-4,100 Reduced 1.86%
216,668 $2.52 Million
Q1 2020

May 06, 2020
BUY
$5.57 - $10.76 $57,081 - $110,268
10,248 Added 4.87%
220,768 $2.38 Million
Q4 2019

Feb 05, 2020
BUY
$7.21 - $8.89 $77,529 - $95,594
10,753 Added 5.38%
210,520 $1.69 Million
Q3 2019

Oct 23, 2019
BUY
$6.57 - $9.46 $62,901 - $90,570
9,574 Added 5.03%
199,767 $1.49 Million
Q2 2019

Aug 14, 2019
BUY
$8.17 - $11.07 $149,984 - $203,223
18,358 Added 10.68%
190,193 $1.77 Million
Q1 2019

May 01, 2019
BUY
$9.63 - $13.09 $1,502 - $2,042
156 Added 0.09%
171,835 $1.92 Million
Q4 2018

Jan 31, 2019
BUY
$10.53 - $15.54 $313,372 - $462,470
29,760 Added 20.97%
171,679 $2.01 Million
Q3 2018

Nov 07, 2018
SELL
$15.25 - $17.72 $58,087 - $67,495
-3,809 Reduced 2.61%
141,919 $2.19 Million
Q2 2018

Aug 06, 2018
BUY
$14.46 - $18.08 $146,725 - $183,457
10,147 Added 7.48%
145,728 $2.4 Million
Q1 2018

May 02, 2018
BUY
$16.77 - $22.04 $61,680 - $81,063
3,678 Added 2.79%
135,581 $2.29 Million
Q4 2017

Feb 09, 2018
BUY
$13.44 - $22.81 $284,376 - $482,636
21,159 Added 19.11%
131,903 $2.49 Million
Q3 2017

Nov 06, 2017
BUY
$19.97 - $22.74 $2.21 Million - $2.52 Million
110,744
110,744 $2.49 Million

Others Institutions Holding OSUR

# of Institutions
202
Shares Held
65.5M
Call Options Held
2.2K
Put Options Held
5.1K
View Full List

About ORASURE TECHNOLOGIES INC

OSUR Quotes by TradingView
  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $277M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email